April 23, 2015 Mini-Lecture Nathan King M.D. Anticoagulation Reversal Part 2: UFH & LMWH.

Slides:



Advertisements
Similar presentations
Evidence-Based Management of Anticoagulant Therapy
Advertisements

Rapid Reversal of Warfarin Therapy in Patients with Intracranial / Intraspinal Bleeding Mount Auburn Hospital Blood Bank, Emergency Department, Critical.
Stroke Workshop Case Scenario.
Controversies in the management of Pulmonary Embolism
Vanderbilt Pediatric Hematology Anticoagulation Guidance Protocol Robert F. Sidonio, Jr. MD, MSc. 4/11/12 Enoxaparin Dosing Goal anti-Xa levels are 0.6.
Warfarin toxicity Presented by: Dr.Somaia Janah Presented by: Dr.Somaia Janah.
Chapter 19 Agents Affecting Blood Clotting. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Blood.
Heparin in CRRT Benan Bayrakci, McLean Antitrombin 3 Inactive Thrombin (IIa) V, VIII, XIII, Fibrinogen Inactive Factor Xa Common Pathway Inactive.
CLINICAL CASES.
Prophylaxis of Venous Thromboembolism
Preventing Anticoagulation Errors with Clinical Dashboards Dan Johnson, Pharm.D., BCPS August 3, 2011.
Study by: Granger et al. NEJM, September 2011,Vol No. 11 Presented by: Amelia Crawford PA-S2 Apixaban versus Warfarin in Patients with Atrial Fibrillation.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 11: The Critically Ill Pregnant Woman.
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
Dalia Elfawy., MD Lecturer of Anesthesia and ICU Ain Shams University 2014 RAPID REVERSAL OF ANTICOAGULATION IN TRAUMA PATIENTS.
BLOOD PHARMACOLOGY Peer Support Case 1 Mrs A recently seen one of your colleagues complaining of fatigue. Her blood test results are now back and.
Core Topic UCI Internal Medicine Residency Learning Objectives Review the major causes of upper GI bleeding and important elements of the history.
NURS 1950 Pharmacology I 1.  Objective 1: identify general reasons anticoagulants are given 2.
Care of the Anti-coagulated Trauma Patient Julie Mayglothling, MD, FACEP Emergencies in Medicine March 8 th, 2012.
Mechanical Clot Detection
Intracerebral Haemorrhage. Clinical Context ICH accounts for up to 15% of first-time strokes and is associated with a 30-day mortality rate between 35%
The Clinical Guide “A Guide to Implementing Renal Best Practice in Haemodialysis“ Chapter 5: Anticoagulation Team Leader: Angela Henson Co-authors: Franta.
Management OF INTRACEREBRAL HEMORRHAGE
Stroke and the ED Kurian Thomas, MD Department of Neurology.
Thrombolytic drugs BY :DR. ISRAA OMAR.
The Evolving Management of Pediatric Stroke Christopher A. Miller, MD July 21, 2012.
Acute venous or arterial thrombosis Acute venous or arterial thrombosis Is there clinical concern for an anatomic compressive syndrome or occlusive iliofemoral.
Complication during pregnancy and its nursing management: - Pregnancy induces hypertension. Clinical Aspect of Maternal and Child Nursing NUR 363 Lecture.
TUESDAY 19TH OCTOBER2010 CATH LAB PRESENTATION. TAO /ACS study STUDY NUMBER: EFC6204 Randomized, double-blind, triple-dummy trial to compare the efficacy.
VCU Death and Complications Conference
NYU Medical Grand Rounds Clinical Vignette Andy Levy, MD PGY-2 March 26, 2013 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Inferior/Right Ventricular Infarction CLINICAL PRESENTATION AND TREATMENT Lady Minto Hospital Emergency Rounds February 2015 Prepared by Shane Barclay.
71-year old male Admitted with worsening shortness of breath PMHx: Severe COPD, A.Fib, CHF/ischemic, PE On long term anticoagulation with Pradaxa 150.
Welcome to the ER. Meet Your Team: Trauma Surgeon ________________ Flight Crew ________________ ER Nurses ER Technicians Radiology Techs ________________.
Treatment of Ischaemic Stroke The American Heart Association American Stroke Association Guidelines Stroke. 2007;38:
Narcotic agonist/narcotic analgesic. Mechanism of Action: Alleviates pain by acting on the pain receptors in the brain; elevates pain threshold. Depresses.
Laboratory investigation should be ordered only when indicated by the patient’s medical status, drug therapy, or the nature of the proposed procedure.
STEMI < 6 h Lytic eligible Lytic choice by MD (TNK, tPA, rPA, SK) ENOX < 75 y: 30 mg IV bolus SC 1.0 mg / kg q 12 h (Hosp DC) ≥ 75 y: No bolus SC 0.75.
Safety and Efficacy of Intravenous Enoxaparin in Elective Percutaneous Coronary Intervention: an International Randomized Evaluation (STEEPLE) Presented.
The INT egrelin and E noxaparin R andomized assessment of A cute C oronary syndrome Treatment T rial Sponsored by the Canadian Heart Research Centre, Key.
Good Morning 6 June Uremic Bleeding: Pathogenesis and Therapy 麻醉科 林子富.
Peri-Operative anticoagulation /antiplatelet therapy A Shift in Paradigm BMHGT04/29/09.
Perioperative Medicine Beyond Cardiac Clearance Pamela Pride MD July 31, 2012 MUSC.
Drugs Susan Louw Haematology Registrar. 4 Questions to ask: Can I stop? (What is the risk of thrombosis?) Should I stop? (What is the risk of bleeding?)
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
Agents Affecting Blood Clotting
Chapter 19 Agents affecting Blood Clotting. Blood Clotting p461 Clotting is necessary to prevent fatal loss of blood from a minor injury Thromboemboli.
Antithrombotic Therapy for VTE: CHEST Guidelines 2016
{ Challenging Case Presentations From South Texas Methodist Hospital REGIONAL SYSTEMS OF CARE DEMONSTRATION PROJECT: MISSION: LIFELINE™ STEMI SYSTEMS ACCELERATOR.
Simon Howard Medical Management of Acute Stroke. Fast Recognition of Stroke With sudden onset neurological symptoms: 'FAST' should be used to screen for.
April 23, 2015 Mini-Lecture Nathan King M.D. Anticoagulation Reversal Part 1: Warfarin.
Outpatient DVT assessment & treatment Daniel Gilada.
CASE PRESENTATION Clifford J Kavinsky, MD, PHD Professor of Medicine and pediatrics Associate Director, Center for Congenital and Structural Heart Disease.
Evidence-Based Management of Anticoagulant Therapy
Rapid Reversal of Warfarin Therapy in Patients with Intracranial / Intraspinal Bleeding Mount Auburn Hospital Blood Bank, Emergency Department, Critical.
Warfarin Toxicity Treatment & Management
ANTICUAGULANT A.Rahimzadeh.B.sc,M.sc Shahid Beheshty university
Ortho Warfarin Dosing Protocol
Thromboprophylaxis during labour and delivery
Use of NOACs is contraindicated for AF patients with mechanical prosthetic valves or moderate- severe mitral stenosis (usually of rheumatic origin). Although.
In the name of God. Management trauma in elderly DR. NIKSOLAT GERIATRICIAN ASSISTANT PROFESSOR, IRAN UNIVERSITY OF MEDICAL SCIENCE.
Anticoagulation Prepared by Cherie Gan.
Module 3 REDUCE THE LIKELIHOOD OF PATIENT HARM ASSOCIATED WITH THE USE OF ANTICOAGULANT THERAPY.
Medication Safety & Anticoagulation
Anticoagulant Reversal
 INDICATIONS AND USAGE  DOSAGE AND ADMINISTRATION  DOSAGE FORMS AND STRENGTHS  WARNINGS AND PRECAUTIONS  ADVERSE REACTIONS  USE IN SPECIFIC POPULATIONS.
ONLY oral unit-dose warfarin, prefilled Fragmin syringes, and premixed heparin drips are used at CHSB.
Venous Thromboembolism Prophylaxis in Hospitalized Patients
Calculate Well’s score for PE (BOX1)
Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 2: ST-Segment Elevation.
Presentation transcript:

April 23, 2015 Mini-Lecture Nathan King M.D. Anticoagulation Reversal Part 2: UFH & LMWH

Objectives

A 52 year old woman with is in the CCU for an NSTEMI. Cardiac catheterization did not reveal significant stenosis. While on a heparin drip she had an acute alteration in mental status and CT head revealed an intracranial hemorrhage with midline shift. Neurosurgery is preparing decompressive craniotomy. What is the next most appropriate next step? A. Treat with FFP B. Treat with Recombinant Factor VIIa C. Treat with Protamine Sulfate D. Treat with Vitamin K1 Case Vignette #1

Case Vignette #2 A 67 year old woman with history of a right lower extremity DVT on 40mg BID Lovenox, presents with acute altered mental status after 3 days of watery diarrhea and one day of decreased urine output. She last received medications more than 12 hours ago. On exam, she is confused, mucous membranes are dry, and her left thigh is much larger than her right. Labs 7 days ago: Hgb 9.3, BUN/Cr 12/1.1 Labs show now: Hgb 7.4, BUN/Cr 55/2.3 CT now: new enlargement muscles in the medial left thigh compared to prior CT What is the most appropriate next step? A. Call Interventional Radiology, treat with IV NovoSeven B. Call Nephrology consult, place HD catheter for emergent dialysis C. Call ACS surgery consult, treat with IV Vitamin K1 D. Call ACS surgery, treat with IV protamine

Mechanism of UFH and LMWH and Reversal LMWH Primarily acts on Xa Longer Half-life (3-6 hrs) Protamine Reversal agent for Heparinoids Heparinoids: Potentiate Antitithrombin III (AT) UFH (Unfractionated Heparin) Half-life shorter (30-60 minutes) Elevates PTT

Indications for anticoagulation reversal Supportive Measures / Monitoring: Support renal function with IVF and avoid nephrotoxins Monitor CBC and coags at lease Q12 hours Clinical Assessment: anticoagulation exposure possible medication interactions laboratory assessment: CBC, renal function, LFTs, and DIC screen

UFH and LMWH Reversal Protamine Dosing 25mg to 50mg boluses usually sufficient Based on timing, dose, and route of heparinoid to reverse Reactions Anaphylaxis can occur after previous exposure Special considerations Incompletely arrests anti-Xa activity of LMWH

UFH Reversal Time since UFH stopped(D) Protamine Dose to Neutralize 100 units of UFH Immediate1 – minutes0.5 – 0.75 >2 hours0.25 – Copyright Lexicomp, Inc. All rights reserved.

LMWH Reversal Administer 1mg of protamine per 1mg enoxaperin Elevation of PTT or continued bleeding at 2-4 hours post dosing Administer 0.5mg of protamine per 1mg enoxaperin Repeat Dosing Copyright Lexicomp, Inc. All rights reserved.

A 52 year old woman with is in the CCU for an NSTEMI. Cardiac catheterization did not reveal significant stenosis. While on a heparin drip she had an acute alteration in mental status and CT head revealed an intracranial hemorrhage with midline shift. Neurosurgery is preparing decompressive craniotomy. What is the next most appropriate next step? A. Treat with FFP B. Treat with Recombinant Factor VIIa C. Treat with Protamine Sulfate D. Treat with Vitamin K1 Case Vignette #1

A 52 year old woman with is in the CCU for an NSTEMI. Cardiac catheterization did not reveal significant stenosis. While on a heparin drip she had an acute alteration in mental status and CT head revealed an intracranial hemorrhage with midline shift. Neurosurgery is preparing decompressive craniotomy. What is the next most appropriate next step? A. Treat with FFP B. Treat with Recombinant Factor VIIa C. Treat with Protamine Sulfate D. Treat with Vitamin K1 Case Vignette #1

Case Vignette #2 A 67 year old woman with history of a right lower extremity DVT on 40mg BID Lovenox, presents with acute altered mental status after 3 days of watery diarrhea and one day of decreased urine output. She last received medications more than 12 hours ago. On exam, she is confused, mucous membranes are dry, and her left thigh is much larger than her right. Labs 7 days ago: Hgb 9.3, BUN/Cr 12/1.1 Labs show now: Hgb 7.4, BUN/Cr 55/2.3 CT now: new enlargement muscles in the medial left thigh compared to prior CT What is the most appropriate next step? A. Call Interventional Radiology, treat with IV NovoSeven B. Call Nephrology consult, place HD catheter for emergent dialysis C. Call ACS surgery consult, treat with IV Vitamin K1 D. Call ACS surgery, treat with IV protamine

Case Vignette #2 A 67 year old woman with history of a right lower extremity DVT on 40mg BID Lovenox, presents with acute altered mental status after 3 days of watery diarrhea and one day of decreased urine output. She last received medications more than 12 hours ago. On exam, she is confused, mucous membranes are dry, and her left thigh is much larger than her right. Labs 7 days ago: Hgb 9.3, BUN/Cr 12/1.1 Labs show now: Hgb 7.4, BUN/Cr 55/2.3 CT now: new enlargement muscles in the medial left thigh compared to prior CT What is the most appropriate next step? A. Call Interventional Radiology, treat with IV NovoSeven B. Call Nephrology consult, place HD catheter for emergent dialysis C. Call ACS surgery consult, treat with IV Vitamin K1 D. Call ACS surgery, treat with IV protamine

IF Suspected of bleeding or bleeding risk on UFH or LMWH: Determine if emergent reversal needed: ICH, emergent surgery, and major bleeding Initiate Supportive Measures and Clinical Assessment Reverse with Protamine: Incomplete arrest of LMWH Protamine treatment guided by route, timing, and dosage Summary